Placeholder Banner

Life Sciences Community Joins Rep. Charlie Dent to Discuss State of the Industry and Positive Impact on Pennsylvania

August 18, 2016

WHAT: Roundtable discussion about the life sciences landscape, including the industry’s economic impact on Pennsylvania, the value of innovation, bioscience education opportunities, NIH funding and research best practices. Rep. Charlie Dent and Hon. Jim Greenwood to deliver remarks

WHO:
• Rep. Charlie Dent (R-PA-15)
• Hon. Jim Greenwood, President & CEO, BIO; former PA Congressman
• Mr. Craig Tucker, Vice President, PA BIO • Dr. Keri Donaldson, Founder, Prescient Medicine
• Dr. Ralf Brandt, CEO & Managing Director, vivoPharm
• Dr. Kent Vrana, Professor & Chair, Penn State Dept. of Pharmacology
• Dr. Mel Billingsley, President & CEO, Life Sciences Greenhouse of Central PA
• Ms. Caitlin Orr, Project Coordinator, Hershey Center for Applied Research
• Mr. Nick Magallanes, Director Federal Government Relations, BIO

WHEN: Tuesday, August 23, 2016, 1:30 to 2:30 p.m. (Eastern Time Zone)

WHERE:
Hershey Center for Applied Research
Room 1103
1214 Research Boulevard
Hummelstown, PA 17036  


https://www.bio.org/sites/default/files/SP_Pennsylvania_0.pdf

 

Discover More
BIO President & CEO John F. Crowley released the following statement:“A healthy and prosperous society is vitally important to the American people and to the world. The public health, economic security and our national security are best served…
“The Biotechnology Innovation Organization (BIO) applauds today's announcement from the USDA's Animal and Plant Health Inspection Service (APHIS) expanding the scope of biotechnology exemptions for modified plants under 7 CFR part 340. This…
BIO strongly supports a manufacturer’s ability to use a 340B rebate as an appropriate option to make 340B pricing available to covered entities."Manufacturers should have the choice to effectuate 340B pricing in the manner they deem most efficient…